论文部分内容阅读
本文旨在回顾性地比较肝细胞肝癌患者在肝切除术前行肝动脉置管化学栓塞术(TAE)和不行栓塞术的治疗效果,用以评估术前TAE的确切作用。 [材料和方法]1.分组:1980.1到1987.12,作者共为138例肝细胞肝癌(HCC)作了肝切除术,其中107例术前不作TAE,另31例术前已在其他医院作过TAE。从这些患者作TAE前的影象学检查和肝功能俭查估计,在作TAE前癌肿均能切除。患者在行TAE后分别被随访7～1245天(130±34天),由于AFP再度升高、肿瘤增大或患者要求而进行了肝切除术。
This article aims to retrospectively compare the therapeutic effect of hepatic artery catheter embolization (TAE) and embolization before hepatectomy in patients with hepatocellular carcinoma to evaluate the exact role of preoperative TAE. [Materials and Methods] 1. Grouping: From 1980.1 to 1987.12, the authors performed a total of 138 hepatocellular carcinoma (HCC) hepatectomy. Among them, 107 patients did not undergo TAE before operation, and another 31 patients had TAE before surgery in other hospitals. . From these patients before TAE imaging examination and liver function survey estimated that before the TAE cancer can be removed. Patients were followed up for 7 to 1245 days (130±34 days) after TAE, and hepatectomy was performed due to re-elevation of AFP, tumor enlargement, or patient’s request.